TSE:OPS

Opsens - OPS Stock Forecast, Price & News

C$2.60

-0.07 (-2.62%)

(As of 10/5/2022 12:38 PM ET)

Add

Compare

Today's Range: C$2.60
▼
C$2.69
50-Day Range: C$2.39
▼
C$3.12
52-Week Range: C$1.55
▼
C$3.74

Volume: 21,139 shs
Average Volume: 126,902 shs
Market Capitalization: C$282.80 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: C$4.45

About Opsens (TSE:OPS) Stock

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology. The Industrial segment develops, manufactures, and installs fiber optic sensing solutions for industrial applications. The company offers OptoWire, an advanced optical-based pressure guidewire that enhances the clinical outcome of patients with coronary artery disease; and OptoMonitor. It also provides fiber optic temperature sensors, pressure sensors, strain sensors, displacement sensors, and extensometers, as well as signal conditioners/OEM boards. It serves various markets, such as life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and other markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. The company is headquartered in Québec, Canada.

Receive OPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Opsens and its competitors with MarketBeat's FREE daily newsletter.

OPS Stock News Headlines

September 24, 2022 | finance.yahoo.com

Acticor Biotech Postpones Release of Its 2022 Half-Year Financial Results - Yahoo Finance

September 24, 2022 | ca.finance.yahoo.com

OPSENS ANNOUNCES FIRST SAVVYWIRE PROCEDURE IN THE UNITED STATES BY DR. PHILIPPE GENEREUX OF MORRISTOWN MEDICAL CENTER - Yahoo Canada Finance

September 19, 2022 | finance.yahoo.com

The Global Distributed Temperature Sensing Market is expected to grow by $ 314.03 mn during 2022-2026, accelerating at a CAGR of 6.85% during the forecast period - Yahoo Finance

September 14, 2022 | finance.yahoo.com

OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in Boston September 16-19, 2022

September 2, 2022 | marketwatch.com

Fractional Flow Reserve Market to Reach Expected Growth of CAGR 10.6% by 2026 | 99 Report Pages

July 15, 2022 | markets.businessinsider.com

What Wall Street expects from Opsens's earnings

June 7, 2022 | finance.yahoo.com

OPSENS ANNOUNCES GLOBAL SAVVYWIRE™ FIRST COMMERCIAL USE

May 18, 2022 | finance.yahoo.com

OPSENS ANNOUNCES PUBLICATION IN JSCAI OF DATA SUPPORTING THE CORRELATION BETWEEN THE OPTOWIRE AND A NOVEL TAVR INTERFACE WITH STANDARD OF CARE, BEFORE AND AFTER TAVR

April 13, 2022 | seekingalpha.com

Opsens Inc.'s (OPSSF) CEO Louis Laflamme on Q2 2022 Results - Earnings Call Transcript

February 9, 2022 | finance.yahoo.com

OPSENS APPOINTS BRAD DAVIS AS NEW CHIEF COMMERCIAL OFFICER

February 1, 2022 | marketwatch.com

Opsens Extends Supply Agreement With Abiomed to April 2028

February 1, 2022 | finance.yahoo.com

OPSENS ANNOUNCES ABIOMED 4-YEAR SUPPLY AGREEMENT EXTENSION TO 2028

January 31, 2022 | ca.finance.yahoo.com

This TSX Stock Has Plunged 32% in 2022: Should You Buy the Dip?

January 24, 2022 | ca.finance.yahoo.com

Stocks in play: Opsens Inc

January 24, 2022 | finance.yahoo.com

OPSENS NAMED TO 2022 OTCQX BEST 50

January 19, 2022 | marketwatch.com

Fractional Flow Reserve Market Size Comprehend by Channel, Distributors, Customers, Research Findings and Forecast to 2024 Says Absolute Reports

January 13, 2022 | finance.yahoo.com

Opsens Inc.'s (TSE:OPS) Shift From Loss To Profit

December 13, 2021 | finance.yahoo.com

OPSENS ANNOUNCES 510(K) SUBMISSION TO U.S. FDA FOR NEW GUIDEWIRE FOR THE TAVR PROCEDURE

October 13, 2021 | msn.com

This Could Be the Next Big TSX Acquisition Target According to Analysts

October 13, 2021 | finance.yahoo.com

OpSens Successfully Treats First Patients in Human Clinical Study for TAVR Procedure

September 20, 2021 | finance.yahoo.com

OPSENS Receives Approval from Health Canada to Initiate First In-Man Clinical Study for its New Guidewire for the TAVR Procedure

August 31, 2021 | finance.yahoo.com

Do Its Financials Have Any Role To Play In Driving Opsens Inc.'s (TSE:OPS) Stock Up Recently?

July 14, 2021 | nasdaq.com

OpSens Sales Rise 39% in Q3

June 9, 2021 | finance.yahoo.com

OpSens will Participate and Present at two Investment Conferences - Lytham Partners and Raymond James

June 4, 2021 | markets.businessinsider.com

Insights on the Fractional Flow Reserve Global Market to 2027 - Featuring Abbott, Boston Scientific and Opsens Among Others

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive OPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Opsens and its competitors with MarketBeat's FREE daily newsletter.

OPS Company Calendar

Last Earnings: 7/14/2022
Today: 10/05/2022
Next Earnings (Estimated): 11/22/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Industry: Scientific & Technical Instruments
Sub-Industry: N/A
Sector: Computer and Technology
Current Symbol: TSE:OPS
CUSIP: N/A
CIK: N/A
Web: opsens.com
Phone: 418-781-0333
Fax: N/A
Employees: 163
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: C$4.45
High Stock Price Forecast: C$6.00
Low Stock Price Forecast: C$3.35
Forecasted Upside/Downside: +71.2%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 18.46
Current Ratio: 5.87
Quick Ratio: 4.88

Sales & Book Value

Annual Sales: C$34.34 million
Price / Sales: 8.24
Cash Flow: C$0.26 per share
Price / Cash Flow: 10.08
Book Value: C$0.35 per share
Price / Book: 7.49

Miscellaneous

Outstanding Shares: 108,771,000
Free Float: N/A
Market Cap: C$282.80 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Alan W. Milinazzo (Age 62)
Exec. Chairman
Comp: $99k

Mr. Louis Laflamme C.A.
CPA, CPA, Pres, CEO & Director

Mr. Robin Villeneuve C.A. (Age 55)
CPA, CFO & Corp. Sec.
Comp: $267.18k

Mr. Brad Davis
Chief Commercial Officer

Mr. Pierre Poulin
Corp. Controller

Key Competitors

View All Competitors

OPS Stock - Frequently Asked Questions

Should I buy or sell Opsens stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Opsens in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OPS shares.
View OPS analyst ratings or view top-rated stocks.
What is Opsens' stock price forecast for 2022?: 3 analysts have issued twelve-month price targets for Opsens' stock. Their OPS share price forecasts range from C$3.35 to C$6.00. On average, they expect the company's share price to reach C$4.45 in the next twelve months. This suggests a possible upside of 67.3% from the stock's current price.
View analysts price targets for OPS or view top-rated stocks among Wall Street analysts.
How have OPS shares performed in 2022?: Opsens' stock was trading at C$3.10 at the start of the year. Since then, OPS shares have decreased by 14.2% and is now trading at C$2.66.
View the best growth stocks for 2022 here.
When is Opsens' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 22nd 2022.
View our OPS earnings forecast.
How were Opsens' earnings last quarter?: Opsens Inc. (TSE:OPS) released its quarterly earnings data on Thursday, July, 14th. The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.02) by $0.01. The firm had revenue of $10.08 million for the quarter, compared to analyst estimates of $8.65 million.

What other stocks do shareholders of Opsens own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Opsens investors own include Acadian Timber (ADN), Agellan Commercial Real Estate Invtmt TR (ACR.UN), AutoCanada (ACQ), ATCO (ACO.X), Accord Financial (ACD), Aurora Cannabis (ACB), Air Canada (AC), Barrick Gold (ABX) and Absolute Software Co. (ABT.TO) (ABT).
What is Opsens' stock symbol?: Opsens trades on the Toronto Stock Exchange (TSX) under the ticker symbol "OPS."
How do I buy shares of Opsens?: Shares of OPS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is Opsens' stock price today?: One share of OPS stock can currently be purchased for approximately C$2.66.
How much money does Opsens make?: Opsens (TSE:OPS) has a market capitalization of C$289.33 million and generates C$34.34 million in revenue each year.
How many employees does Opsens have?: The company employs 163 workers across the globe.
How can I contact Opsens?: The official website for the company is opsens.com. The company can be reached via phone at 418-781-0333.

This page (TSE:OPS) was last updated on 10/5/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial